TNFAIP3
Tumor necrosis factor alpha-induced protein 3
Also known as: A20, OTUD7C, TNAP3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P21580
- Gene
- TNFAIP3
- Ensembl
- ENSG00000118503
- Chromosome
- 6
- Canonical length
- 790 aa
- Protein class
- Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Centrosome,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene was identified as a gene whose expression is rapidly induced by the tumor necrosis factor (TNF). The protein encoded by this gene is a zinc finger protein and ubiqitin-editing enzyme, and has been shown to inhibit NF-kappa B activation as well as TNF-mediated apoptosis. The encoded protein, which has both ubiquitin ligase and deubiquitinase activities, is involved in the cytokine-mediated immune and inflammatory responses. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2012]
Canonical amino-acid sequenceUniProt
790 residues, UniProt reviewed canonical sequence.
>P21580|TNFAIP3
1 MAEQVLPQAL YLSNMRKAVK IRERTPEDIF KPTNGIIHHF KTMHRYTLEM FRTCQFCPQF
61 REIIHKALID RNIQATLESQ KKLNWCREVR KLVALKTNGD GNCLMHATSQ YMWGVQDTDL
121 VLRKALFSTL KETDTRNFKF RWQLESLKSQ EFVETGLCYD TRNWNDEWDN LIKMASTDTP
181 MARSGLQYNS LEEIHIFVLC NILRRPIIVI SDKMLRSLES GSNFAPLKVG GIYLPLHWPA
241 QECYRYPIVL GYDSHHFVPL VTLKDSGPEI RAVPLVNRDR GRFEDLKVHF LTDPENEMKE
301 KLLKEYLMVI EIPVQGWDHG TTHLINAAKL DEANLPKEIN LVDDYFELVQ HEYKKWQENS
361 EQGRREGHAQ NPMEPSVPQL SLMDVKCETP NCPFFMSVNT QPLCHECSER RQKNQNKLPK
421 LNSKPGPEGL PGMALGASRG EAYEPLAWNP EESTGGPHSA PPTAPSPFLF SETTAMKCRS
481 PGCPFTLNVQ HNGFCERCHN ARQLHASHAP DHTRHLDPGK CQACLQDVTR TFNGICSTCF
541 KRTTAEASSS LSTSLPPSCH QRSKSDPSRL VRSPSPHSCH RAGNDAPAGC LSQAARTPGD
601 RTGTSKCRKA GCVYFGTPEN KGFCTLCFIE YRENKHFAAA SGKVSPTASR FQNTIPCLGR
661 ECGTLGSTMF EGYCQKCFIE AQNQRFHEAK RTEEQLRSSQ RRDVPRTTQS TSRPKCARAS
721 CKNILACRSE ELCMECQHPN QRMGPGAHRG EPAPEDPPKQ RCRAPACDHF GNAKCNGYCN
781 ECFQFKQMYGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TNFAIP3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 394 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 394 nTPM
- urinary bladder: 146 nTPM
- appendix: 86 nTPM
- ovary: 65 nTPM
- thymus: 60 nTPM
- lymph node: 55 nTPM
Single-cell type
- neutrophils: 5,956 nCPM
- innate lymphoid cells: 2,537 nCPM
- mast cells: 2,207 nCPM
- endometrial luminal cells: 1,915 nCPM
- endometrial glandular cells: 1,903 nCPM
- monocytes: 1,643 nCPM
Immune cell
- MAIT T-cell: 15 nTPM
- T-reg: 12 nTPM
- gdT-cell: 12 nTPM
- memory CD4 T-cell: 11 nTPM
- memory CD8 T-cell: 11 nTPM
- plasmacytoid DC: 9.2 nTPM
Brain region
- cerebral cortex: 25 nTPM
- choroid plexus: 13 nTPM
- thalamus: 10 nTPM
- spinal cord: 7.8 nTPM
- medulla oblongata: 7.5 nTPM
- pons: 7.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TNFAIP3.
Disease | AllUniProt
Conditions TNFAIP3 is implicated in, by any mechanism.
- Autoinflammatory syndrome, familial, Behcet-like 1 (AIFBL1) MIM:616744
Disease | GeneticClinVar
91 pathogenic / likely-pathogenic of 740 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autoinflammatory syndrome, familial, Behcet-like 1
- Autoinflammatory syndrome, familial, Behcet-like
- Neoplasm
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.2
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.45
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- B-1 B cell homeostasis
- cell migration
- cellular response to hydrogen peroxide
- cellular response to lipopolysaccharide
- cytoskeleton organization
- inflammatory response
- negative regulation of B cell activation
- negative regulation of bone resorption
- negative regulation of canonical NF-kappaB signal transduction
- negative regulation of CD40 signaling pathway
- negative regulation of chronic inflammatory response
- negative regulation of endothelial cell apoptotic process
- negative regulation of extrinsic apoptotic signaling pathway via death domain receptors
- negative regulation of inflammatory response
- negative regulation of innate immune response
- negative regulation of interleukin-1 beta production
- negative regulation of interleukin-2 production
- negative regulation of interleukin-6 production
- negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway
- negative regulation of osteoclast proliferation
- negative regulation of protein ubiquitination
- negative regulation of smooth muscle cell proliferation
- negative regulation of toll-like receptor 2 signaling pathway
- negative regulation of toll-like receptor 3 signaling pathway
- negative regulation of toll-like receptor 4 signaling pathway
- negative regulation of tumor necrosis factor production
- nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway
- positive regulation of hepatocyte proliferation
- positive regulation of protein catabolic process
- positive regulation of Wnt signaling pathway
- protein deubiquitination
- protein deubiquitination involved in ubiquitin-dependent protein catabolic process
- protein K11-linked deubiquitination
- protein K48-linked deubiquitination
- protein K48-linked ubiquitination
- protein K63-linked deubiquitination
- regulation of defense response to virus by host
- regulation of germinal center formation
- regulation of tumor necrosis factor-mediated signaling pathway
- response to molecule of bacterial origin
- response to muramyl dipeptide
- tolerance induction to lipopolysaccharide
- establishment of protein localization to vacuole
- negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway
- negative regulation of toll-like receptor 5 signaling pathway
- regulation of vascular wound healing
Molecular functions
- cysteine-type deubiquitinase activity
- DNA binding
- identical protein binding
- K63-linked deubiquitinase activity
- K63-linked polyubiquitin modification-dependent protein binding
- kinase binding
- protease binding
- ubiquitin binding
- ubiquitin-protein transferase activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TNFAIP3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TNFAIP3 as an antibody target. Whether an autoantibody or antibody against TNFAIP3 could matter depends on whether native TNFAIP3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TNFAIP3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TNFAIP3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...